von BOETTICHER Rechtsanwälte Partnerschaftsgesellschaft mbB advises across the pharmaceutical sector with a particular focus on pharmaceutical advertising law, which start-ups as well as international pharmaceutical companies regularly call upon. The team's mainstays include the enforcement of claims in interim injunction proceedings pertaining to pharmaceuticals and medical devices as well as the advice on distribution law in the context of vaccines and healthcare-related agreements. Claudia Böhm handles competition and product law issues.
Legal 500 Editorial commentary
Key clients
- Aceto GmbH
- Acino-Gruppe
- Bavarian-Nordic GmbH
- Betterguards GmbH
- CellAct Pharma GmbH
- Cellbricks GmbH
- EVER Neuro Pharma GmbH (AT); EVER Pharma GmbH (DE); EVER Valinject GmbH (DE)
- Gilead Sciences GmbH
- LEO Pharma GmbH
- Lipotype GmbH
- Madaus & Lauscher GmbH
- Nekonal S.a.r.l. (Lux)
- Sanochemia Pharmazeutika GmbH
- Sedana Medical AB (pub)
- Tillotts Pharma AG Schweiz, Tillotts-Gruppe
Work highlights
- Representation of a research-based international pharmaceutical company in disputes with various competitors from the vaccine sector.
- Advising EVER Neuro Pharma GmbH on the expansion of pharmaceutical production at several domestic and foreign locations of the Gerresheimer Group.
- Representation of Gilead Sciences GmbH (among others) in competition law disputes with ViiV Healthcare GmbH concerning new scientific data.